Bold Voices - January 2011 - (Page 12)

AT THE BEDSIDE Chronic Lung Disease of Prematurity Increases Respiratory Risk in Day Care When in day care, young children and infants with chronic lung disease of prematurity (CLDP) are at increased risk for morbidity from respiratory viral infections, fi nds a study in October’s Pediatrics. “Day Care Increases the Risk of Respiratory Morbidity in Chronic Lung Disease of Prematurity” includes parent surveys and data from 111 CLDP patients ages 3 and younger. Collected data — perinatal history, sociodemographic information, day care attendance and indicators of respiratory morbidity — show increased emergency department visits, hospitalizations, systemic corticosteroid use, antibiotic use and respiratory symptoms, it adds. Study inforMost of the catch-up mation notes, lung growth occurs “Children with CLDP who attended daycare (22 out of the 111) were nearly four times more likely to end up in the ER with serious respiratory symptoms than during the first two those who didn’t attend daycare, were twice as likely to need corticosteroids, and were more than twice as likely to need antibiotics. Children who attended years of life. daycare were nearly three times more likely to have breathing problems at least once a week compared to those not attending daycare.” Researchers advise parents to avoid sending children with CLDP to day care in their fi rst two years of life, because “most of the catch-up lung growth occurs during that time. Most children with CLDP improve with age as their lungs mature, but about one-fourth continue to have respiratory problems as adults,” study information adds. Methylphenidate: An Option for Childhood Cancer Survivors Childhood cancer survivors who used Methylphenidate (MPH) over the course of a year experienced attention and behavioral benefits, fi nds a study published online Sept. 13 by the Journal of Clinical Oncology. “Long-Term Efficacy of Methylphenidate in Enhancing Attention Regulation, Social Skills and Academic Abilities of Childhood Cancer Survivors” looked at the long-term effectiveness of maintenance doses of MPH in survivors of childhood brain tumors and acute lymphoblastic leukemia. The study’s purpose notes that MPH “ameliorates attention problems” some cancer survivors experience in the short term, “but its long-term efficacy is unproven.” According to a Reuters article, Heather M. Conklin, a pediatric neuropsychologist at St. Jude Children’s Research Hospital, Memphis, Tenn., for tests.” She adds that the fi ndings suggest that MPH can be “considered an option for child cancer survivors.” In her practice, Conklin discusses the option with parents. She notes, however, that “the drug would typically be just one element of a strategy that includes certain school accommodations” such as seating the child at the front of the classroom, giving the child shorter homework assignments and “teaching kids tactics for making schoolwork and testtaking easier — such as studying in quiet settings, with frequent breaks,” the article adds. MPH improves attention problems. Its long-term efficacy is unproven. says “anecdotally,” some parents in her study said their children’s grades improved, which appeared to be related to “improvements in the kids’ ability to fi nish their homework and study 12 JANUARY 2011

Table of Contents for the Digital Edition of Bold Voices - January 2011

Front/Digital Edition Viewing Guide
Another Angle
AACN Boards and Contact Information
New HHS-CCSC Awards Recognize HAI Reductions
Zero Tolerance for Preventable Incidents Involves Non-Surgical Specialties
Bold Voice: Chatting with MaryAnn Stump
Facebook Asthma?
EOL Care Rises for Heart Failure Patients on Medicare
More Patient, Family Contact Needed in EOL Care
Chronic Lung Disease of Prematurity Increases Respiratory Risk in Day Care
Childhood Obesity Linked to Viral Infections
Pharmaceutical Safety at Home
DTaP, Tdap: What's in a Name?
In Our Journals
STOP-BANG Helps Identify Surgical Patients at Risk
Fewer Blood Transfusions Can Improve Patient Safety, Reduce Costs
Certification Capsules
Dues, NTI and Certification Fees Will Not Increase
From the President

Bold Voices - January 2011